$16.59
0.03% today
Nasdaq, Feb 28, 05:17 pm CET
ISIN
US53222K2050
Symbol
LFVN
Sector
Industry

LifeVantage Corporation Stock price

$16.58
-4.93 22.92% 1M
+7.83 89.49% 6M
-0.95 5.42% YTD
+9.71 141.34% 1Y
+11.30 213.97% 3Y
+4.91 42.09% 5Y
+10.09 155.38% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.50 2.93%
ISIN
US53222K2050
Symbol
LFVN
Sector
Industry

Key metrics

Market capitalization $208.10m
Enterprise Value $199.27m
P/E (TTM) P/E ratio 29.34
EV/FCF (TTM) EV/FCF 15.47
EV/Sales (TTM) EV/Sales 0.94
P/S ratio (TTM) P/S ratio 0.98
P/B ratio (TTM) P/B ratio 6.96
Dividend yield 0.87%
Last dividend (FY24) $0.55
Revenue growth (TTM) Revenue growth 0.57%
Revenue (TTM) Revenue $212.15m
EBIT (operating result TTM) EBIT $10.84m
Free Cash Flow (TTM) Free Cash Flow $12.88m
Cash position $21.60m
EPS (TTM) EPS $0.57
P/E forward 22.71
P/S forward 0.87
EV/Sales forward 0.83
Short interest 5.86%
Show more

Is LifeVantage Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

LifeVantage Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a LifeVantage Corporation forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a LifeVantage Corporation forecast:

Buy
100%

Financial data from LifeVantage Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
212 212
1% 1%
100%
- Direct Costs 43 43
0% 0%
20%
169 169
1% 1%
80%
- Selling and Administrative Expenses 154 154
3% 3%
73%
- Research and Development Expense 0.90 0.90
29% 29%
0%
14 14
70% 70%
7%
- Depreciation and Amortization 3.30 3.30
29% 29%
2%
EBIT (Operating Income) EBIT 11 11
194% 194%
5%
Net Profit 7.34 7.34
148% 148%
3%

In millions USD.

Don't miss a Thing! We will send you all news about LifeVantage Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeVantage Corporation Stock News

Positive
MarketBeat
16 days ago
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permitted when drugs are listed on the FDA's list of drug shortages.
Positive
Seeking Alpha
22 days ago
LifeVantage Corporation's Q2/FY2025 results were boosted by the successful launch of the MindBody GLP-1 system. LFVN revenues jumped by more than 40% on a sequential basis, while free cash flow of $8.7 million represented a new multi-year high. However, elevated commissions and incentive expenses impacted profitability, thus resulting in a rather mediocre Adjusted EBITDA margin of 9.6%.
Neutral
Seeking Alpha
23 days ago
LifeVantage Corporation (NASDAQ:LFVN ) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Reed Anderson – Managing Director-ICR Steve Fife – President and Chief Executive Officer Carl Aure – Chief Financial Officer Conference Call Participants Aaron Wukmir – Lake Street Capital Markets Alex Fuhrman – Craig-Hallum Capital Group Doug Lane – Water Tower Research Oper...
More LifeVantage Corporation News

Company Profile

LifeVantage Corp. engages in the identification, research, development, and distribution of advanced nutraceutical dietary supplements and personal care products. It operates through the Americas Region; and Asia/Pacific and Europe Region georaphical segments. The firm's products include Protandim, LifeVantage® Omega+ and ProBio, TrueScience, and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

Head office United States
CEO Steven Fife
Employees 222
Founded 1988
Website www.lifevantage.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today